HighPoint Resources Corporation (NYSE:HPR)
HighPoint Resources Corporation (NYSE:HPR) represented a move of 7.67 percent or $-0.12 per share and closed its previous day trading session at $3.51. 2.35 Million Shares were traded in the last trading session with an Average Volume of 2.1 Million Shares. The stock currently has a Market Capitalization of 777.68 Million.
HighPoint Resources Corporation is an exploration and production company. It focuses on the development of oil and natural gas assets primarily in the Denver-Julesburg Basin of Colorado. HighPoint Resources Corporation, formerly known as Bill Barrett Corporation, is based in Denver, Colorado.
The stock traded between $3.20 and $7.60 over 1-Year time period showing its price to sales ratio of 1.92. HighPoint Resources Corporation (NYSE:HPR) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-16.96 and 200-Day Simple Moving Average of $-35.45. Its Price to Free Cash Flow is 4.19 and Price to Book of 0.75.
Analyst’s recommended the stock as 1.9 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, HighPoint Resources Corporation (NYSE:HPR) reported its Actual EPS of $0.01/share. The analysts offering Earnings Estimates for the company were believing that HighPoint Resources Corporation could bring EPS of $0.02/share. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Thus showing an Earnings Surprise of -50 Percent.
Mednax, Inc (NYSE:MD)
In the last trading session, Mednax, Inc (NYSE:MD) added its value by 0.65% closing at the price of $40.46. The stock currently has market capitalization of 3.61 Billion, with average volume of 907.39 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Mednax, Inc (NYSE:MD) is showing beta of 0.32. This particular value of beta suggests that Mednax, Inc (NYSE:MD) has historically moved 32% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Mednax, Inc (NYSE:MD) is at $2.96.
The stock currently has RSI of 47.4. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives.
Mednax, Inc (NYSE:MD) topped its 52-week high price of $63.04 on 03/08/18 and 52-Week Low Price of $37.26 on 11/01/18. The Stock currently has P/E (price to earnings ttm) of 13.68 and Weekly volatility of 1.65% and monthly volatility of 2.49% respectively.